NAV
$19.88
AUM
$2.6M
Expense Ratio
-
Dividend Yield
0.00%
Beta
1.50
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +5.82% | +16.12% | +22.77% | +15.54% | +3.60% | - |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | IQV | IQVIA Holdings Inc | 8.46% |
| 2 | DXCM | DexCom Inc | 8.34% |
| 3 | VEEV | Veeva Systems Inc Class A | 7.95% |
| 4 | ISRG | Intuitive Surgical Inc | 7.00% |
| 5 | RMD | ResMed Inc | 6.18% |
| 6 | GH | Guardant Health Inc | 5.73% |
| 7 | ILMN | Illumina Inc | 5.03% |
| 8 | NTRA | Natera Inc | 4.46% |
| 9 | ALGN | Align Technology Inc | 3.82% |
| 10 | GMED | Globus Medical Inc Class A | 3.56% |
The fund will normally invest at least 80% of its net assets (plus any borrowings for investment purposes) in the common stocks and depositary receipts that comprise the index. The index is designed to measure the performance of a selection of companies that are primarily engaged in and involved at the intersection of healthcare and technology, as classified by Lux Capital based on analysis of the products and services offered by those companies. The fund is non-diversified.
Inception Date: 2022-03-22